STAT | Reporting from the frontiers of health and medicine Follow STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact. https://www.statnews.com/2026/09/17/astrazeneca-enhertu-breast-cancer-england-nice-pricing-agreement-us-trade-deal/ statnews.com
